Protein Partnership Leads To Pediatric Tumor Regression
Why are some pediatric cancers able to spontaneously regress? Prof. Michael Fainzilber and his team in the Weizmann Institute's Biological Chemistry Department seem to have unexpectedly found part of the answer. Further research toward a better understanding of the mechanism of action might hopefully lead, in the future, to the development of drugs that will be able to induce regression of certain tumors.
No comments:
Post a Comment